Effect of O Acetylation of Neisseria meningitidis Serogroup A Capsular Polysaccharide on Development of Functional Immune Responses
Open Access
- 1 July 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (7) , 3707-3713
- https://doi.org/10.1128/iai.70.7.3707-3713.2002
Abstract
The importance of O-acetyl groups to the immunogenicity of Neisseria meningitidis serogroup A polysaccharide (PS) was examined in studies using human sera and mouse immunization. In 17 of 18 postimmunization human sera, inhibition enzyme-linked immunosorbent assay indicated that the majority of antibodies binding to serogroup A PS were specific for epitopes involving O-acetyl groups. Studies with mice also showed an essential role for O-acetyl groups, where serum bactericidal titers following immunization with de-O-acetylated (de-O-Ac) conjugate vaccine were at least 32-fold lower than those following immunization with O-Ac PS-conjugate vaccine and 4-fold lower than those following immunization with native capsular PS. Inhibition studies using native and de-O-Ac PS confirmed the specificity of murine antibodies to native PS. The dramatic reduction in immunogenicity associated with removal of O-acetyl groups indicates that O acetylation is essential to the immunogenic epitopes of serogroup A PS. Since levels of bactericidal antibodies are correlated with protection against disease, O-acetyl groups appear to be important in protection.Keywords
This publication has 23 references indexed in Scilit:
- Timely detection of meningococcal meningitis epidemics in AfricaThe Lancet, 2001
- Evaluation of De-O-Acetylated Meningococcal C Polysaccharide-Tetanus Toxoid Conjugate Vaccine in Infancy: Reactogenicity, Immunogenicity, Immunologic Priming, and Bactericidal Activity against O-Acetylated and De-O-Acetylated Serogroup C StrainsInfection and Immunity, 2001
- Haemophilus influenzae Invasive Disease in the United States, 1994–1995: Near Disappearance of a Vaccine-Preventable Childhood DiseaseEmerging Infectious Diseases, 1998
- Induction of Immunologic Memory in Gambian Children by Vaccination in Infancy with a Group A plus Group C Meningococcal Polysaccharide-Protein Conjugate VaccineThe Journal of Infectious Diseases, 1997
- A Trial Of A Group A Plus Group C Meningococcal Polysaccharide-ProteinThe Journal of Infectious Diseases, 1995
- Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and CVaccine, 1992
- Epidemic Meningococcal Disease in Nairobi, Kenya, 1989The Journal of Infectious Diseases, 1992
- AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINEThe Lancet, 1985
- Serum Antibodies to Capsular Polysaccharide Vaccine of Group A Neisseria meningitidis Followed for Three Years in Infants and ChildrenThe Journal of Infectious Diseases, 1980
- Structures of the Capsular Polysaccharides of Neisseria meningitidis as Determined by 13C-Nuclear Magnetic Resonance SpectroscopyThe Journal of Infectious Diseases, 1977